Fig. 5From: Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer CellsIn vitro release profiles of DXR from PLV/DXR in phosphate buffered saline at pH 7.4 vs 5.4 at different times after dialysisBack to article page